Oligosaccharide nucleic acids promote CRC progression by regulating the Mir-650/ANXA2 axis and enhance oxaliplatin resistance in CRC cells by polarizing M2 macrophages [71]. The gene discussed is ANXA2; the disease is colorectal carcinoma.